Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

   Single User - $2,500
   Site License (one location, 10 users) - $3,750
   Corporate License - $5,000

Published Apr 20, 2016 | 50 Pages | Pub ID: KLI5975604

Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

Blood Testing Market in China (Typing, Immunoassay, NAT Testing) offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The data gathered are the result of interviews conducted with experts and blood banking professionals in China. This report provides market sizing and forecasts for the major types of blood bank tests in the Chinese market. It also provides province-level statistics on the number of blood centers and the types of blood centers.

Blood Testing Market in China provides market analysis and data on the blood testing market environment in China, including:
  • Blood Center Stations in China by Type (Provincial, Regional, County, Cord, Plasma, Other)
  • China Blood Supply Statistics
  • Blood Supply Centers in Beijing
  • Blood Supply in China (tons)
  • Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
  • Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Progress of Conversion (Provincial, Regional, County, Plasma Collection) Percentage Using NAT Testing
There are some 497 blood collection centers in China. The types of blood centers differ from provincial level, county level and regional medical centers. The report provides province-level statistics on the number of blood centers and the types of blood centers, including the number of blood supply stations and stations for collection of plasma. Data are provided for the following provinces:
  • Beijing
  • Guangdong
  • Henan
  • Shaanxi
  • Guangxi
  • Heilongjiang
  • Yunnan
Blood Testing Market in China offers an assessment of the current blood supply in the country, making conclusions regarding China’s demand for blood, progress in the collection and testing of blood, and the capacity for NAT testing and opportunities for makers of NAT equipment. The report also estimates the market for blood testing and typing equipment in China in 2015 and 2020.

The report profiles companies in the market and speculates on the best opportunities for test makers. Companies profiled include:
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Roche
  • China Health Labs & Diagnostics, Ltd.
  • Daan Gene Co., Ltd.
U.S. dollar figures represent the Chinese market and are expressed in current dollars. Sales estimates are provided for 2015 and forecasts are provided through 2020. Information for this report was gathered using both primary and secondary research sources. Kalorama Information, working with The Freedonia Group’s office in Beijing, conducted primary research rounds including interviews with national experts and managers at blood collection centers across China. Certain provincial blood centers were a focus of the study to offer a mix of rural and urban provinces, including Shaanxi, Guangdong, Beijing, Henan, Yunnan, and Heilongjiang. The report also benefited from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts’ reports and other sources.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.